Sariguna Primatirta Tbk PT
IDX:CLEO

Watchlist Manager
Sariguna Primatirta Tbk PT Logo
Sariguna Primatirta Tbk PT
IDX:CLEO
Watchlist
Price: 472 IDR 1.72% Market Closed
Market Cap: 11.3T IDR

Sariguna Primatirta Tbk PT
Net Income (Common)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Sariguna Primatirta Tbk PT
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Sariguna Primatirta Tbk PT
IDX:CLEO
Net Income (Common)
Rp439.3B
CAGR 3-Years
31%
CAGR 5-Years
27%
CAGR 10-Years
N/A
Akasha Wira International Tbk PT
IDX:ADES
Net Income (Common)
Rp665.7B
CAGR 3-Years
22%
CAGR 5-Years
43%
CAGR 10-Years
40%
Tri Banyan Tirta Tbk PT
IDX:ALTO
Net Income (Common)
-Rp42.5B
CAGR 3-Years
-87%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
No Stocks Found

Sariguna Primatirta Tbk PT
Glance View

PT Sariguna Primatirta engages in the business of bottled water. The company is headquartered in Sidoarjo, Jawa Timur and currently employs 412 full-time employees. The company went IPO on 2017-05-05. The Company’s segments include Bottle, Non Bottle and Others. The firm offers its bottled drinking water under various brands, such as Anda, Cleo Platine, S-Tube, Supero2, Vio and Cleo. The firm has approximately 27 total factories across Indonesia.

CLEO Intrinsic Value
658.52 IDR
Undervaluation 28%
Intrinsic Value
Price

See Also

What is Sariguna Primatirta Tbk PT's Net Income (Common)?
Net Income (Common)
439.3B IDR

Based on the financial report for Sep 30, 2025, Sariguna Primatirta Tbk PT's Net Income (Common) amounts to 439.3B IDR.

What is Sariguna Primatirta Tbk PT's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
27%

Over the last year, the Net Income (Common) growth was 2%. The average annual Net Income (Common) growth rates for Sariguna Primatirta Tbk PT have been 31% over the past three years , 27% over the past five years .

Back to Top